Greg Shelton

After joining AGC Biologics as Global Vice President Legal Affairs in July of 2021, Greg Shelton was appointed to the Executive Leadership Team as General Counsel and Corporate Secretary on April 1, 2022. Greg brings more than 25 years of experience and legal expertise in the pharmaceutical, biotech, medical device and healthcare spaces. Before joining AGC Biologics, Greg served as Division Counsel and Senior Leadership Team member for Stryker Emergency Care – a $1.1 billion division of Stryker Corporation. Prior to Stryker, Greg represented a notable roster of multi-national companies at high-performing law firms in both Seattle and New York City. He also holds author’s credit within numerous legal publications.

Greg earned his Bachelor of Art, Philosophy from University of Massachusetts and his Juris Doctor from Vermont Law School.